MyFinsight
Home
About
Contact
stro: the income statement
Download
Download image
Net loss
-$56,857K
(-16.54%↓ Y/Y)
Loss before
provision for income taxes
-$56,857K
(-16.54%↓ Y/Y)
Interest income
$2,009K
(-58.79%↓ Y/Y)
Vaxcyte Inc
$129K
Astellas Pharma Inc
Astellas
$9,564K
Interest and other income
(expense), net
-$737K
(-103.32%↓ Y/Y)
Non-cash interest
expense related to the...
$9,670K
(22.25%↑ Y/Y)
Loss from operations
-$48,459K
(28.65%↑ Y/Y)
Revenue
$9,693K
(13.77%↑ Y/Y)
Total operating
expenses
$58,152K
(-23.92%↓ Y/Y)
Restructuring and related
costs
$9,558K
General and
administrative
$8,741K
(-39.01%↓ Y/Y)
Research and development
$39,853K
(-35.83%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)